awards grant
- BRIDGE (Blood cancer Research Initiative Developing Greater Engagement) with Community Patients
- Defining the role of DNA methylation modifier mutations in reshaping blood differentiation topology
- Discovery and therapeutic targeting of novel mechanisms driving Double Hit Lymphomas
- Exploring the roles of EZH2 mutation for the development of double hit lymphoma and acquisition of chemotherapy resistance
- Preventing follicular lymphoma progression and transformation through precision therapy
- Restoring lymphoma immunosurveillance by combined EZH2 inhibition and immunotherapy.
- Targeting Unmet Needs For B-cell Lymphomas
- Targeting the microenvironment to increase immunity and immunotherapy response in DLBCL
- The Role of SPEN as Tumor Suppressor in BN2 DLBCL